Testing effectiveness (Phase 2)Ended earlyNCT02162758
What this trial is testing
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Who this might be right for
Barrett's Esophagus
Takeda 6